Literature DB >> 11990837

Surgical treatment of lumbar stenosis in achondroplasia.

Ralph T W Thomeer1, J Marc C van Dijk.   

Abstract

OBJECT: The authors conducted a study to evaluate the results of a unique surgical procedure for treating primary lumbar stenosis in patients with achondroplasia, based on its distorted anatomical dimensions.
METHODS: A consecutive single-center series of 36 achondroplastic dwarfs with symptomatic lumbar stenosis underwent dynamic lumbar myelography to determine the most stenotic lumbar segment. This level was surgically decompressed by selective widening of the lumbar interapophyseolaminar diameter; laminectomy was not performed. The L2-3 level was decompressed in 97% of the cases and the L1-2 and L3-4 levels in 58 and 61%, respectively. Lower lumbar levels were rarely affected by stenosis. Stenosis typically did not occur at the level of the lamina, where the pseudoscalloping of the vertebral body compensates for the spinal narrowing, obviating the need for laminectomy. Complete relief of symptoms was demonstrated in 25 (71.4%) of 35 patients. Tolerable disease remained in eight patients (22.9%) postoperatively. In two cases (5.7%) surgery resulted in no benefit. One case was lost to follow up. The presence of a lumbar epidural hematoma complicated one procedure.
CONCLUSIONS: In this series the interapophyseolaminar decompression was demonstrated to be an effective and safe procedure for the treatment of symptomatic stenosis in achondroplasia. The upper lumbar segments, particularly the L2-3 level, were most frequently involved. Dynamic lumbar myelography proved mandatory in demonstrating the symptomatic level.

Entities:  

Mesh:

Year:  2002        PMID: 11990837     DOI: 10.3171/spi.2002.96.3.0292

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Foetal surgery and using in utero therapies to reduce the degree of disability after birth. Could it be morally defensible or even morally required?

Authors:  Constantinos Kanaris
Journal:  Med Health Care Philos       Date:  2017-03

Review 2.  Advances in research on and diagnosis and treatment of achondroplasia in China.

Authors:  Yao Wang; Zeying Liu; Zhenxing Liu; Heng Zhao; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2013-05

3.  Surgical treatment of spinal stenosis in achondroplasia: Literature review comparing results in adults and paediatrics.

Authors:  Zaid Abu Al-Rub; Beth Lineham; Zaid Hashim; John Stephenson; Lydia Arnold; Jennifer Campbell; Peter Loughenbury; Almas Khan
Journal:  J Clin Orthop Trauma       Date:  2021-10-30

4.  High prevalence of symptomatic spinal stenosis in Norwegian adults with achondroplasia: a population-based study.

Authors:  Svein O Fredwall; Unni Steen; Olga de Vries; Cecilie F Rustad; Heidi Beate Eggesbø; Harald Weedon-Fekjær; Ingeborg B Lidal; Ravi Savarirayan; Grethe Månum
Journal:  Orphanet J Rare Dis       Date:  2020-05-25       Impact factor: 4.123

5.  Clinical Practice Guidelines for Achondroplasia.

Authors:  Takuo Kubota; Masanori Adachi; Taichi Kitaoka; Kosei Hasegawa; Yasuhisa Ohata; Makoto Fujiwara; Toshimi Michigami; Hiroshi Mochizuki; Keiichi Ozono
Journal:  Clin Pediatr Endocrinol       Date:  2020-01-09

6.  Achondroplasia with seronegative spondyloarthropathy resulting in recurrent spinal stenosis : A case report.

Authors:  Rajendra Sakhrekar; Shailesh Hadgaonkar; Manisha Hadgaonkar; Parag Sancheti; Ashok Shyam
Journal:  Surg Neurol Int       Date:  2021-07-19

7.  Multilevel thoracic and lumbar ligamentum flavum ossification in an achondroplasic-a rare presentation.

Authors:  Ankur Nanda; Kuldeep Bansal; Anuj Gupta; Kalyan Verma; Jitesh Manghwani; H S Chhabra
Journal:  Spinal Cord Ser Cases       Date:  2021-07-31

8.  Lumbar spinal stenosis and disc alterations affect the upper lumbar spine in adults with achondroplasia.

Authors:  Thomas Huet; Martine Cohen-Solal; Jean-Denis Laredo; Corinne Collet; Geneviève Baujat; Valérie Cormier-Daire; Alain Yelnik; Philippe Orcel; Johann Beaudreuil
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.